Jenny T. Mao
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 4
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 16
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 7
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Oncology top 10%
- Chemokine receptors and signaling 3
-
- Estrogen and related hormone effects 7
-
- Genomics, phytochemicals, and oxidative stress 6
-
- Cancer, Stress, Anesthesia, and Immune Response 5
- Co-authors
- Steven M. DubinettDonald P. TashkinSherven SharmaMichael D. RothQing‐Yi LuÉva SzabóZuo‐Feng ZhangKostyantyn Krysan
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Jenny T. Mao
44 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 112
- Biochemistry 125
- Pharmacology 330
- Cancer Research 267
- Pulmonary and Respiratory Medicine 443
- Oncology 369
Countries citing papers authored by Jenny T. Mao
This map shows the geographic impact of Jenny T. Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny T. Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny T. Mao more than expected).
Fields of papers citing papers by Jenny T. Mao
This network shows the impact of papers produced by Jenny T. Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny T. Mao. The network helps show where Jenny T. Mao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jenny T. Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 6 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 1 | |
| 5 | 2013 | 40 | |
| 6 | 2011 | 65 | |
| 7 | 2010 | 247 | |
| 8 | 2010 | 43 | |
| 9 | 2009 | 13 | |
| 10 | 2008 | 21 | |
| 11 | 2008 | 115 | |
| 12 | 2008 | 96 | |
| 13 | 2007 | 20 | |
| 14 | 2006 | 6 | |
| 15 | Cyclooxygenase-2 dependent expression of angiogenic CXC chemokines, ENA-78/CXCL5 and IL-8/CXCL8, in human non-small cell lung cancer | 2004 | 1 |
| 16 | 2004 | 74 | |
| 17 | Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers. | 2003 | 38 |
| 18 | 2003 | 56 | |
| 19 | 2002 | 125 | |
| 20 | 1996 | 38 |
About Jenny T. Mao
Jenny T. Mao is a scholar working on Pharmacology, Cancer Research and Biochemistry, having authored 44 papers that have together received 1.7k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (16 papers), Cancer, Lipids, and Metabolism (7 papers), Estrogen and related hormone effects (7 papers), Genomics, phytochemicals, and oxidative stress (6 papers), Cancer, Stress, Anesthesia, and Immune Response (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Chemokine receptors and signaling (3 papers). The work is most often cited by research in Biochemistry (125 citations), Pharmacology (330 citations) and Cancer Research (267 citations). Jenny T. Mao has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Steven M. Dubinett, Donald P. Tashkin, Sherven Sharma, Michael D. Roth, Qing‐Yi Lu, Éva Szabó, Zuo‐Feng Zhang, Kostyantyn Krysan, Katherine A. Peebles and Felicita Baratelli.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.